In the line of fire
India’s IP laws have been in the eye of a storm since it issued its first ever Compulsory Licence. Will they land us into the list…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Why are Indian generics under attack? One view from America
Giving a view from America, Roger Bate shares his impressions on the quality of generic drugs in India and opines that the CDSCO,…
Thomson Reuters names 2014 leading drugs to watch
Analysis points to three potential blockbusters: Sovaldi, Anoro Ellipta and Idelalisib entering market this year
Patent protection losses will hinder HIV treatment market growth within seven years: GBI Research
The first-line antiretroviral therapies Atripla and Truvada will lose patent protection during the forecast period, which will…
Waters Corporation launches NuGenesis Lab Management System
Powerful alternative to LIMS offers seamless lab-to-business connection for science-driven organisations
DTAB receives leadership in Animal Welfare Award
Recommended a ban on the import of cosmetics tested on animals as well as the manufacture and sale of oxytocin
Battling on Different Fronts
The pharma sector in Maharashtra is facing challenges from different quarters, including bureaucratic hurdles, unwarranted…
’Maharashtra is the hub of quality medicines’
Maharashtra still dominates the Indian pharma sector, emphasises Mahesh Zagade, Commissioner, FDA Maharashtra, in conversation…
Glenmark consolidated revenue increases by 27.53% to Rs. 17,035.60 million in Q4 FY 2013-14
EBITDA grew by 46.7 per cent to Rs 3816.17 millionGlenmark Pharmaceuticals announced its full year results for the year ended…